FTO-CHRM3 axis regulates multiple myeloma progression: a machine learning-based identification.
Bo Lu1, Ting Bin1, Xue-Fei Deng1
1Department of Haematology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518000, China.
Annals of Hematology
|March 23, 2026
Summary
Fat Mass and Obesity-Associated (FTO) protein promotes multiple myeloma (MM) progression through the FTO-CHRM3 axis, impacting DNA replication and cell cycle. This research offers new therapeutic targets for MM.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Fat Mass and Obesity-Associated (FTO) gene is implicated in multiple myeloma (MM) progression.
- The precise mechanisms of FTO's role in MM remain largely unknown.
Purpose of the Study:
- To investigate the role and mechanisms of FTO in multiple myeloma (MM).
- To identify FTO-associated genes and their impact on the MM immune microenvironment.
Main Methods:
- Machine learning and correlation analyses to identify FTO-associated genes.
- Immunohistochemistry to validate gene expression in MM tissues.
- Immune infiltration and single-cell RNA sequencing (scRNA-seq) to analyze the immune microenvironment and cellular expression patterns.
Main Results:
- FTO is upregulated in MM and linked to poor prognosis.
- Identified CHRM3, GINS3, RRM2, and SHCBP1 as potential FTO-associated genes, with a focus on the FTO-CHRM3 axis.
- FTO and CHRM3 are involved in DNA replication and cell cycle; altered M2 macrophage and eosinophil infiltration observed.
- scRNA-seq revealed monocyte-specific SLC8A1 expression in the calcium signaling pathway.
Conclusions:
- The FTO-CHRM3 axis drives MM progression through calcium signaling pathway dysregulation.
- Understanding these mechanisms provides potential targets for MM interventions.
Related Concept Videos
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression
1.6K
1.6K


